Search

everythinglearnresearchcommunity

for

Search:↓

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

Topical 0.1% tacrolimus improved a rare ear condition in cats.

Tph cells are linked to the severity of systemic lupus erythematosus.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Tofacitinib may effectively treat folliculitis decalvans.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.